Incidence, prevalence, and temporal trends of colorectal cancer across age, sex, race, and ethnicity: A large real-world analysis.

L Logesh Durairaj (Rochester Regional Health, Unity Hospital, New York, NY) A Anushree Venkatesh Murthy (Rochester Regional Health, Unity Hospital, Rochester, NY) A Adithya Nagendran (1Rochester Regional Hospital, Internal Medicine, Rochester, United States) M Madho Mal (4Marshall University Joan C. Edwards School of medicine, Huntington, United States) L Love Kumar (5Vandalia Health, Charleston, United States) N Nayanika Chowdary Tummala (NYMC at St. Mary’s General Hospital and Saint Clare’s Health, Denville, NJ)

Abstract

e15699 Background: Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality in the United States. Recent epidemiologic data suggest rising CRC incidence among younger adults and persistent disparities across demographic groups. Using a large real-world database, we evaluated temporal trends in CRC incidence and prevalence from 2020 to 2024. Methods: We conducted a retrospective observational study using the TriNetX Global Collaborative Network, comprising data from 166 healthcare organizations and approximately 188 million patients. CRC cases were identified using ICD-10-CM codes C18–C20. Annual incidence proportion, prevalence, and incidence rates (cases per person-day) were calculated and stratified by age, sex, race, and ethnicity. Results: From 2020 to 2024, CRC incidence and prevalence increased steadily across all demographic groups. Overall incidence proportion rose from approximately 0.03% to 0.045–0.05%, while prevalence increased from roughly 0.10% to 0.14–0.16%. Incidence rates nearly doubled over the study period. CRC burden increased markedly with age, with the highest incidence rates observed among individuals aged ≥70 years. Although absolute rates remained low, adults aged 20–39 years demonstrated relative increases in incidence over time. Males consistently exhibited higher incidence and prevalence than females. Racial disparities persisted, with increasing incidence among Black, White, and Asian patients, and the highest prevalence observed in patients with unknown race. Conclusions: In this large real-world analysis, CRC incidence and prevalence increased steadily from 2020 to 2024 across all demographic groups. Rising incidence among younger adults, alongside persistent sex- and race-based disparities, underscores the need for equitable, risk-adapted screening strategies and improved access to preventive care.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

L

Logesh Durairaj

Rochester Regional Health, Unity Hospital, New York, NY

A

Anushree Venkatesh Murthy

Rochester Regional Health, Unity Hospital, Rochester, NY

A

Adithya Nagendran

1Rochester Regional Hospital, Internal Medicine, Rochester, United States

M

Madho Mal

4Marshall University Joan C. Edwards School of medicine, Huntington, United States

L

Love Kumar

5Vandalia Health, Charleston, United States

N

Nayanika Chowdary Tummala

NYMC at St. Mary’s General Hospital and Saint Clare’s Health, Denville, NJ